Z-1125-2019 Class II Terminated
FDA device recall Z-1125-2019 was initiated by Roche Diagnostics Corporation on Dec 14, 2018 and is designated Class II. Reason for recall: COBAS INTEGRA¿ 400 plus and cobas c 111 analyzers Additional Extra Wash Cycle Configurations and/or Batch Mode Needed for Specific Tests Due to Carry-over The recall status is terminated (terminated Sep 4, 2020). Affected quantity: 137 units.
Recall details
- Product Type
- Devices
- Report Date
- Apr 17, 2019
- Initiation Date
- Dec 14, 2018
- Termination Date
- Sep 4, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 137 units
Product description
cobas c 111 with ISE analyzers analyzer used in the following assays: a)Creatinine plus ver.2 Catalog Number: 05401470190; b)Triglycerides Catalog Number: 04657594190 - Product Usage: Tina-quant Apolipoprotein A-1 ver.2 A lipoprotein test system is a device intended to measure lipoprotein in serum and plasma. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders and atherosclerosis Tina-quant Albumin Gen.2 Immunoturbidimetric assay for the quantitative, in vitro determination of albumin in human urine, serum, plasma, and CSF on Roche/Hitachi cobas c systems
Reason for recall
COBAS INTEGRA¿ 400 plus and cobas c 111 analyzers Additional Extra Wash Cycle Configurations and/or Batch Mode Needed for Specific Tests Due to Carry-over
Distribution pattern
US Nationwide distribution.
Code information
All
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1125-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026